日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review

阿尼弗鲁单抗治疗系统性红斑狼疮难治性口腔表现：病例报告及文献综述

期刊:Biologics-Targets & Therapy
影响因子:3.4
doi:10.2147/BTT.S588071
Garmish, Olena; Smiyan, Svitlana; Komorovsky, Roman; Bilozetskyi, Ivan
红斑狼疮
免疫/内分泌
发表日期：2026
文献求助 收藏

The Effects of Disease-Modifying Antirheumatic Drugs on Cardiovascular Risk in Inflammatory Joint Diseases: Current Evidence and Uncertainties

改善病情抗风湿药物对炎症性关节疾病患者心血管风险的影响：现有证据和不确定性

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S523939
Garmish, Olena; Smiyan, Svitlana; Hladkykh, Fedir; Koshak, Bohdan; Komorovsky, Roman
炎症/感染
炎症
发表日期：2025
文献求助 收藏

Infection-Triggered Antiphospholipid Syndrome: A Critical Overview

感染诱发的抗磷脂综合征：关键概述

期刊:Open Access Rheumatology-Research and Reviews
影响因子:2.3
doi:10.2147/OARRR.S541224
Smiyan, Svitlana; Kuzmina, Ganna; Garmish, Olena; Komorovsky, Roman
炎症/感染
发表日期：2025
文献求助 收藏

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies

filgotinib 对患有炎症性疾病的男性患者精液参数和性激素的影响：来自 2 期随机、双盲、安慰剂对照 MANTA 和 MANTA-RAy 研究的结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2023-224017
Reinisch, Walter; Hellstrom, Wayne; Dolhain, Radboud J E M; Sikka, Suresh; Westhovens, René; Mehta, Rajiv; Ritter, Timothy; Seidler, Ursula; Golovchenko, Oleksandr; Simanenkov, Vladimir; Garmish, Olena; Jeka, Sławomir; Moravcová, Radka; Rajendran, Vijay; Le Brun, Franck-Olivier; Arterburn, Sarah; Watkins, Timothy R; Besuyen, Robin; Vanderschueren, Dirk
炎症/感染
NTA
炎症
免疫/内分泌
发表日期：2023
文献求助 收藏

Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study

在既往未接受过生物制剂治疗的中重度类风湿关节炎患者中，DRL_RI 与参考利妥昔单抗的药代动力学相似性及药效学、安全性、疗效和免疫原性比较：一项双盲、随机、三臂研究

期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-020-00406-1
Haridas, Vikram Muralidhar; Katta, Rahul; Nalawade, Ajit; Kharkar, Sandeep; Zhdan, Vyacheslav; Garmish, Olena; Lopez-Lazaro, Luis; Batra, Sonica Sachdeva; Kankanwadi, Suresh
关节炎
免疫/内分泌
发表日期：2020
文献求助 收藏

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

利妥昔单抗换用生物类似药CT-P10治疗类风湿性关节炎的疗效和安全性：一项随机3期试验的72周数据

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kez152
Shim, Seung Cheol; Božić-Majstorović, Ljubinka; Berrocal Kasay, Alfredo; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco Fidencio; Medina-Rodriguez, Francisco G; Miranda, Pedro; Shesternya, Pavel; Chavez-Corrales, Jose; Wiland, Piotr; Jeka, Slawomir; Garmish, Olena; Hrycaj, Pawel; Fomina, Natalia; Park, Won; Suh, Chang-Hee; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Yoo, Dae Hyun
关节炎
发表日期：2019
文献求助 收藏

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

生物类似药 CT-P10 与原研药利妥昔单抗在类风湿性关节炎患者中的比较：一项随机对照 III 期试验

期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2018.1487912
Park, Won; Božić-Majstorović, Ljubinka; Milakovic, Dragana; Berrocal Kasay, Alfredo; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Molina, Francisco Fidencio Cons; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G; Wiland, Piotr; Jeka, Slawomir; Chavez-Corrales, Jose; Garmish, Olena; Linde, Thomas; Rekalov, Dmytro; Hrycaj, Pawel; Krause, Andreas; Fomina, Natalia; Piura, Olena; Abello-Banfi, Mauricio; Suh, Chang-Hee; Shim, Seung Cheol; Lee, Sang Joon; Lee, Sung Young; Kim, Sung Hwan; Yoo, Dae Hyun
关节炎
发表日期：2018
文献求助 收藏